Results 21 to 30 of about 1,655 (156)

Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: a systematic review of clinical trials [PDF]

open access: yesFrontiers in Psychiatry
IntroductionPsychedelic agents have regained the attention of pharmaceutical companies as promising treatments for depressive episodes. 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT), an atypical psychedelic, is emerging as a potentially effective, novel ...
Aleksander Kwaśny   +2 more
doaj   +3 more sources

5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice. [PDF]

open access: yesNeuropsychopharmacology, 2023
Serotonergic psychedelics are gaining increasing interest as potential therapeutics for a range of mental illnesses. Compounds with short-lived subjective effects may be clinically useful because dosing time would be reduced, which may improve patient access.
Jefferson SJ   +12 more
europepmc   +3 more sources

Corrigendum: A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus [PDF]

open access: yesFrontiers in Molecular Neuroscience, 2019
Rafael Vitor Lima da Cruz   +4 more
doaj   +2 more sources

Molecular Docking, MM-GBSA, and Molecular Dynamics Approach: 5-MeO-DMT Analogues as Potential Antidepressants. [PDF]

open access: yesArch Razi Inst, 2023
Since depression is a common mental illness affecting an estimated 5% of people worldwide, investigators are encouraged to develop effective antidepressants. According to the monoamine-deficiency hypothesis, the underlying pathophysiology of depression is a deficiency of some neurotransmitters (serotonin, norepinephrine, or dopamine) in the central ...
Kalirajan R   +5 more
europepmc   +2 more sources

Author Correction: 5-MeO-DMT induces sleep-like LFP spectral signatures in the hippocampus and prefrontal cortex of awake rats [PDF]

open access: yesScientific Reports
Annie C. Souza   +9 more
doaj   +2 more sources

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers

open access: yesFrontiers in Pharmacology, 2021
5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) is a tryptamine with ultra-rapid onset and short duration of psychedelic effects. Prospective studies for other tryptamines have suggested beneficial effects on mental health outcomes.
Johannes Reckweg   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy